Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04485949
Title A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma - the ImmuneSense Study
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Imvax
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.